Clinical Trial Update: Immunogenicity, Safety, and Tolerability of a Plant-Derived Quadrivalent VLP Influenza Vaccine in Elderly Adults [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing immunogenicity, safety, and tolerability of a plant-derived quadrivalent VLP influenza vaccine in elderly adults has been compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Tract Diseases
• Rna Virus Infections
• Virus Diseases

Drugs mentioned

• plant-derived quadrivalent VLP influenza vaccine

Snippet

Sponsor: Medicago | Conditions: Virus Diseases, RNA Virus Infections | Phase 2 | Status: COMPLETED